Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mirae Biotech is a South Korean biotechnology company primarily focused on animal health, nutrition, and human diagnostics. As a subsidiary of Easy Holdings, the company develops and manufactures a diverse portfolio of products including veterinary pharmaceuticals, feed additives, probiotics, and enzyme-based solutions. Mirae Biotech leverages advanced fermentation and bio-material technologies to enhance livestock productivity and welfare. In recent years, the company expanded its capabilities into the human healthcare sector by developing in vitro diagnostic solutions, including RT-PCR kits for COVID-19. Operating from its headquarters and manufacturing facilities in Gyeonggi-do, Mirae Biotech serves both domestic and international markets in the livestock, aquaculture, and diagnostic sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirae Biotech.